Background: It remains unclear whether patients with autoimmune rheumatic diseases (ARDs) are at a higher risk of poor outcomes from a SARS-CoV-2 infection. We evaluated whether patients with an ARDs infected with SARS-CoV-2 were at a higher risk of a poorer outcome than those without an ARDs.
Methods: Patients with an ARDs infected with SARS-CoV-2 were matched to control patients without a known ARDs.
© LitMetric 2025. All rights reserved.